Cathay Biotech (SHSE:688065) Interest Expense : ¥-36 Mil (TTM As of Mar. 2024)

View and export this data going back to 2020. Start your Free Trial

What is Cathay Biotech Interest Expense?

Interest Expense is the amount reported by a company or individual as an expense for borrowed money. Cathay Biotech's interest expense for the three months ended in Mar. 2024 was ¥ -10 Mil. Its interest expense for the trailing twelve months (TTM) ended in Mar. 2024 was ¥-36 Mil.

Interest Coverage is a ratio that determines how easily a company can pay interest expenses on outstanding debt. It is calculated by dividing a company's Operating Income(EBIT) by its Interest Expense. Cathay Biotech's Operating Income for the three months ended in Mar. 2024 was ¥ 96 Mil. Cathay Biotech's Interest Expense for the three months ended in Mar. 2024 was ¥ -10 Mil. Cathay Biotech's Interest Coverage for the quarter that ended in Mar. 2024 was 9.70. The higher the ratio, the stronger the company's financial strength is. Note: If both Interest Expense and Interest Income are empty, while Net Interest Income is negative, then use Net Interest Income as Interest Expense.

Cathay Biotech Interest Expense Historical Data

The historical data trend for Cathay Biotech's Interest Expense can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Cathay Biotech Interest Expense Chart

Cathay Biotech Annual Data

Trend

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Interest Expense

Get a 7-Day Free Trial

-17.03

-3.86

-16.29

-20.01

-32.17

Cathay Biotech Quarterly Data
	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24
Interest Expense	Get a 7-Day Free Trial															-6.27	-10.20	-6.57	-9.14	-9.93

Cathay Biotech Interest Expense Calculation

Interest Expense is the amount reported by a company or individual as an expense for borrowed money.

Interest Expense for the trailing twelve months (TTM) ended in Mar. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was ¥-36 Mil.

Cathay Biotech (SHSE:688065) Interest Expense Explanation

Note: If both Interest Expense and Interest Income are empty, while Net Interest Income is negative, then use Net Interest Income as Interest Expense.

Cathay Biotech's Interest Expense for the three months ended in Mar. 2024 was ¥-10 Mil. Its Operating Income for the three months ended in Mar. 2024 was ¥96 Mil. And its Long-Term Debt & Capital Lease Obligation for the three months ended in Mar. 2024 was ¥598 Mil.

Cathay Biotech's Interest Coverage for the quarter that ended in Mar. 2024 is calculated as

Interest Coverage	=	-1	*	Operating Income (Q: Mar. 2024 )	/	Interest Expense (Q: Mar. 2024 )
	=	-1	*	96.295	/	-9.929
	=	9.70

The higher the ratio, the stronger the company's financial strength is.

Cathay Biotech (SHSE:688065) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Basic Materials » Chemicals » Cathay Biotech Inc (SHSE:688065) » Definitions » Interest Expense

Traded in Other Exchanges

N/A

Address

1690 Cailun Road, 4th Floor, Building 5, China (Shanghai) Pilot Free Trade Zone, Shanghai, CHN, 201203

Website

https://www.cathaybiotech.com

Cathay Biotech Inc is engaged in production of revolutionary products, including bio-based polyamide,bio-based DN5 (1,5-pentanediamine), long chain dibasic acids (LCDA) and biobutanol. The company's commercial development platform focuses on research of molecular biology, fermentation process engineering, polymer material. Its products include Dibasic Acids, Pentamethylene Diamine, and Bio-based Polyamide.

Cathay Biotech (SHSE:688065) Headlines

No Headlines